Skip to main content
logo
Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · Real-Time Price · USD
63.27
+11.98 (23.36%)
At close: Apr 13, 2026, 4:00 PM EDT
62.91
-0.36 (-0.57%)
Pre-market: Apr 14, 2026, 5:55 AM EDT

Spyre Therapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
102
Market Cap
4.97B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025---
Dec 31, 2024---
Dec 31, 2023886.00K-1.44M-61.96%
Dec 31, 20222.33M-16.41M-87.57%
Dec 31, 202118.74M--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Apellis Pharmaceuticals1.00B
Caris Life Sciences812.03M
Corcept Therapeutics761.41M
Amicus Therapeutics634.21M
TG Therapeutics616.29M
Xenon Pharmaceuticals7.50M
CRISPR Therapeutics AG3.51M
Dianthus Therapeutics2.04M
Revenue Rankings

SYRE News

More News